Cell-Based Therapy for Silicosis

Joint Authors

Lopes-Pacheco, Miquéias
Bandeira, Elga
Morales, Marcelo M.

Source

Stem Cells International

Issue

Vol. 2016, Issue 2016 (31 Dec. 2015), pp.1-9, 9 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2016-03-15

Country of Publication

Egypt

No. of Pages

9

Abstract EN

Silicosis is the most common pneumoconiosis globally, with higher prevalence and incidence in developing countries.

To date, there is no effective treatment to halt or reverse the disease progression caused by silica-induced lung injury.

Significant advances have to be made in order to reduce morbidity and mortality related to silicosis.

In this review, we have highlighted the main mechanisms of action that cause lung damage by silica particles and summarized the data concerning the therapeutic promise of cell-based therapy for silicosis.

American Psychological Association (APA)

Lopes-Pacheco, Miquéias& Bandeira, Elga& Morales, Marcelo M.. 2016. Cell-Based Therapy for Silicosis. Stem Cells International،Vol. 2016, no. 2016, pp.1-9.
https://search.emarefa.net/detail/BIM-1116691

Modern Language Association (MLA)

Lopes-Pacheco, Miquéias…[et al.]. Cell-Based Therapy for Silicosis. Stem Cells International Vol. 2016, no. 2016 (2015), pp.1-9.
https://search.emarefa.net/detail/BIM-1116691

American Medical Association (AMA)

Lopes-Pacheco, Miquéias& Bandeira, Elga& Morales, Marcelo M.. Cell-Based Therapy for Silicosis. Stem Cells International. 2016. Vol. 2016, no. 2016, pp.1-9.
https://search.emarefa.net/detail/BIM-1116691

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1116691